Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Jale Muslehiddinoglu, PhD
Vice President of Strategic Innovation at ST Pharm
Speaker

Profile

Jale Muslehiddinoglu, Ph.D. is Vice President of Strategic Innovation at ST Pharm. Jale has 22 years of industry experience working at pharma and biotech companies and leading technical teams to develop, implement and commercialize API processes. Prior to joining ST Pharm, Jale developed strategies and capabilities for new modalities. She played a key role building lab and production capabilities for oligonucleotides from development, manufacturing and supply chain perspectives. Jale introduced novel approaches for the development of oligonucleotides. She involved in initiatives like EPOC, oligonucleotide networking event.
Jale received her doctorate in chemical engineering from Pennsylvania State University.

Agenda Sessions

  • Beyond Capacity: Rethinking Oligonucleotide Development and Manufacturing for Next-Generation Modalities

    , 12:20pm
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Jale at TIDES USA: Oligonucleotide & Peptide Therapeutics